Results: 28
Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1117, doi. 10.1111/cas.13955
- By:
- Publication type:
- Article
LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR‐10a‐5p/NCOR2 axis in hepatocellular carcinoma cells.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 973, doi. 10.1111/cas.13950
- By:
- Publication type:
- Article
Maintenance of long remission in adult T‐cell leukemia by Tax‐targeted vaccine: A hope for disease‐preventive therapy.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 849, doi. 10.1111/cas.13948
- By:
- Publication type:
- Article
Pharmacologic characterization of fluzoparib, a novel poly(ADP‐ribose) polymerase inhibitor undergoing clinical trials.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1064, doi. 10.1111/cas.13947
- By:
- Publication type:
- Article
REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 962, doi. 10.1111/cas.13946
- By:
- Publication type:
- Article
Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1054, doi. 10.1111/cas.13945
- By:
- Publication type:
- Article
Distinct chemotherapy‐associated anti‐cancer immunity by myeloid cells inhibition in murine pancreatic cancer models.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 903, doi. 10.1111/cas.13944
- By:
- Publication type:
- Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
- By:
- Publication type:
- Article
Roles of EphA1/A2 and ephrin‐A1 in cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 841, doi. 10.1111/cas.13942
- By:
- Publication type:
- Article
Inhibiting the MCM8‐9 complex selectively sensitizes cancer cells to cisplatin and olaparib.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1044, doi. 10.1111/cas.13941
- By:
- Publication type:
- Article
Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 888, doi. 10.1111/cas.13933
- By:
- Publication type:
- Article
Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 858, doi. 10.1111/cas.13938
- By:
- Publication type:
- Article
Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1096, doi. 10.1111/cas.13937
- By:
- Publication type:
- Article
ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1105, doi. 10.1111/cas.13936
- By:
- Publication type:
- Article
Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 875, doi. 10.1111/cas.13934
- By:
- Publication type:
- Article
Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 950, doi. 10.1111/cas.13940
- By:
- Publication type:
- Article
KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1012, doi. 10.1111/cas.13932
- By:
- Publication type:
- Article
PIK3CD induces cell growth and invasion by activating AKT/GSK‐3β/β‐catenin signaling in colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 997, doi. 10.1111/cas.13931
- By:
- Publication type:
- Article
Population‐based cohort study on health effects of asbestos exposure in Japan.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1076, doi. 10.1111/cas.13930
- By:
- Publication type:
- Article
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild‐type p53.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 939, doi. 10.1111/cas.13928
- By:
- Publication type:
- Article
Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 926, doi. 10.1111/cas.13924
- By:
- Publication type:
- Article
Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1021, doi. 10.1111/cas.13923
- By:
- Publication type:
- Article
DANCR‐mediated microRNA‐665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 913, doi. 10.1111/cas.13921
- By:
- Publication type:
- Article
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1085, doi. 10.1111/cas.13920
- By:
- Publication type:
- Article
Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 985, doi. 10.1111/cas.13918
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 840, doi. 10.1111/cas.13672
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 837, doi. 10.1111/cas.13671
- Publication type:
- Article
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 867, doi. 10.1111/cas.13919
- By:
- Publication type:
- Article